(2RS,4R)-2-(4-Hydroxyphenyl)thiazolidine-4-carboxylic acid

ID: ALA584591

Chembl Id: CHEMBL584591

PubChem CID: 13946769

Max Phase: Preclinical

Molecular Formula: C10H11NO3S

Molecular Weight: 225.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)[C@@H]1CSC(c2ccc(O)cc2)N1

Standard InChI:  InChI=1S/C10H11NO3S/c12-7-3-1-6(2-4-7)9-11-8(5-15-9)10(13)14/h1-4,8-9,11-12H,5H2,(H,13,14)/t8-,9?/m0/s1

Standard InChI Key:  TWPYJYQNZHPNGQ-IENPIDJESA-N

Associated Targets(non-human)

Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACP5 Tartrate-resistant acid phosphatase type 5 (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 225.27Molecular Weight (Monoisotopic): 225.0460AlogP: 1.18#Rotatable Bonds: 2
Polar Surface Area: 69.56Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 2.60CX Basic pKa: 6.49CX LogP: -0.81CX LogD: -1.60
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.70Np Likeness Score: 0.34

References

1. Song ZC, Ma GY, Lv PC, Li HQ, Xiao ZP, Zhu HL..  (2009)  Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.,  44  (10): [PMID:19423200] [10.1016/j.ejmech.2009.04.014]
2. Hussein WM, Feder D, Schenk G, Guddat LW, McGeary RP..  (2018)  Purple acid phosphatase inhibitors as leads for osteoporosis chemotherapeutics.,  157  [PMID:30107365] [10.1016/j.ejmech.2018.08.004]

Source